However, the major risk factors for progression of SSc-ILD include diffuse involvement of the skin, the presence of ATA, elevated CRP, worse PFT at baseline, and greater ILD extent on HRCT [13,36]. This evidence concerns the gene CRP and interstitial lung disease.